Literature DB >> 17038031

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.

M Horstink1, E Tolosa, U Bonuccelli, G Deuschl, A Friedman, P Kanovsky, J P Larsen, A Lees, W Oertel, W Poewe, O Rascol, C Sampaio.   

Abstract

The aim of the study was to provide evidence-based recommendations for the management of early (uncomplicated) Parkinson's disease (PD), based on a review of the literature. Uncomplicated PD refers to patients suffering from the classical motor syndrome of PD only, without treatment-induced motor complications and without neuropsychiatric or autonomic problems. MEDLINE, Cochrane Library and International Network of Agencies for Health Technology Assessment (INAHTA) database literature searches were conducted. National guidelines were requested from all European Federation of Neurological Societies (EFNS) societies. Non-European guidelines were searched for using MEDLINE. Part I of the guidelines deals with prevention of disease progression, symptomatic treatment of motor features (parkinsonism), and prevention of motor and neuropsychiatric complications of therapy. For each topic, a list of therapeutic interventions is provided, including classification of evidence. Following this, recommendations for management are given, alongside ratings of efficacy. Classifications of evidence and ratings of efficacy are made according to EFNS guidance. In cases where there is insufficient scientific evidence, a consensus statement (good practice point) is made.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038031     DOI: 10.1111/j.1468-1331.2006.01547.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  57 in total

1.  Pharmacotherapy in Parkinson's disease: case studies.

Authors:  Tiago Mestre; Joaquim J Ferreira
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

2.  Factors associated with exercise behavior in people with Parkinson disease.

Authors:  Terry Ellis; James T Cavanaugh; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Lisa Fredman; Jennifer K Boudreau; Leland E Dibble
Journal:  Phys Ther       Date:  2011-10-14

3.  Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses.

Authors:  Tiago A Mestre; Prakesh Shah; Connie Marras; George Tomlinson; Anthony E Lang
Journal:  Neurology       Date:  2014-03-21       Impact factor: 9.910

4.  Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson's Disease.

Authors:  Mark Dominic Latt; Simon Lewis; Olfat Zekry; Victor S C Fung
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

5.  Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B.

Authors:  Pankaj Pandey; Narayan D Chaurasiya; Babu L Tekwani; Robert J Doerksen
Journal:  Biochem Pharmacol       Date:  2018-06-26       Impact factor: 5.858

6.  Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.

Authors:  Elena Soto; Sebastian Haertter; Michael Koenen-Bergmann; Alexander Staab; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2009-12-29       Impact factor: 4.200

Review 7.  Cost effectiveness of pharmacotherapies in early Parkinson's disease.

Authors:  Karla M Eggert; Jens P Reese; Wolfgang H Oertel; Richard Dodel
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Drug-induced urinary retention: incidence, management and prevention.

Authors:  Katia M C Verhamme; Miriam C J M Sturkenboom; Bruno H Ch Stricker; Ruud Bosch
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease.

Authors:  Hatice Kumru; Alex Iranzo; Eva Carrasco; Francesc Valldeoriola; Maria José Marti; Joan Santamaria; Eduard Tolosa
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

10.  Neuroticism and extraversion in association with quality of life in patients with Parkinson's disease.

Authors:  Tatiana Dubayova; Iveta Nagyova; Eva Havlikova; Jaroslav Rosenberger; Zuzana Gdovinova; Berrie Middel; Jitse P van Dijk; Johan W Groothoff
Journal:  Qual Life Res       Date:  2008-11-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.